# A Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese Subjects

> **NCT01407016** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 6 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** metronidazole IV 500 mg

## Key facts

- **NCT ID:** NCT01407016
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2011-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01407016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01407016, "A Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01407016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*